BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15788299)

  • 1. Delayed radiation myelopathy after concurrent chemoradiation for hypopharyngeal-esophageal carcinoma.
    Chan L; Yeo W; Leung SF; Griffith J; Ng EK; Chan AT
    Acta Oncol; 2005; 44(2):177-9. PubMed ID: 15788299
    [No Abstract]   [Full Text] [Related]  

  • 2. [A pharyngo-esophageal cancer in a patient with Plummer Vinson syndrome. (Apropos of a case)].
    Sid'Ahmed L; Boubacar A; Aye M; Alhousseini Ag M
    Mali Med; 2010; 25(2):56-7. PubMed ID: 21435998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delayed radiation myelopathy].
    Haltia M; Fogelholm R; Andersson L
    Duodecim; 1974; 90(8):602-6. PubMed ID: 4409131
    [No Abstract]   [Full Text] [Related]  

  • 4. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited commentary.
    Piehler JM
    Ann Thorac Surg; 2005 Oct; 80(4):1183-4. PubMed ID: 16181837
    [No Abstract]   [Full Text] [Related]  

  • 7. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
    Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
    Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous radiotherapy plus brachytherapy and concurrent chemotherapy for patients with localized esophageal carcinoma--Radiation Oncology Group Study 9207].
    Kovàcs G;
    Strahlenther Onkol; 2001 May; 177(5):269-70. PubMed ID: 11398614
    [No Abstract]   [Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
    Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy rapidly alternating with twice-a-day accelerated radiation therapy in carcinomas involving the hypopharynx or esophagus: an update.
    Yu L; Vikram B; Malamud S; Yudelman I; Nussbaum M; Beattie E
    Cancer Invest; 1995; 13(6):567-72. PubMed ID: 7583705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
    Maurel J; Cervantes A; Conill C; Salazar R; Martin-Richard M; Pera M; Manzano H; Chirivella I; Gallego R; Marfa X
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):91-6. PubMed ID: 15850907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe interstitial pneumopathy due to herpes virus after radiochemotherapy for esophageal carcinoma].
    Egreteau J; Boucher E; Lesimple T; Le Prisé E; Raoul JL
    Bull Cancer; 2001 Nov; 88(11):1091-3. PubMed ID: 11741803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
    Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
    Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas.
    Liberman PH; Schultz C; Gomez MV; Carvalho AL; Pellizzon AC; Testa JR; Feher O; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1265-8. PubMed ID: 15545579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary combined-modality therapy for esophageal cancer.
    Minsky BD
    Oncology (Williston Park); 2006 Apr; 20(5):497-505; discussion 505-6, 511-3. PubMed ID: 16739747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiation using low-dose cisplatin and 5-fluorouracil in locally advanced squamous cell carcinoma of the skin: a report of two cases.
    Fujisawa Y; Umebayashi Y; Ichikawa E; Kawachi Y; Otsuka F
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S81-5. PubMed ID: 17052540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
    Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
    Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
    Nemoto K; Yamada S; Nishio M; Aoki M; Nakamura R; Matsumoto Y; Sasamoto R; Saitoh Y; Takayama M; Mitsuhashi N; Gomi K; Kanesaka N; Kobayashi M; Ohnishi H; Sasaki S; Tamamura H; Mitsumori M; Nishimura Y; Tsujino K; Takemoto M; Uchida N; Yamamoto M; Shioyama Y; Hirakawa K; Ono S;
    Anticancer Res; 2006; 26(2B):1507-12. PubMed ID: 16619565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.